Features

Managing Acute Vaso-Occlusive Crises in Sickle Cell Disease

By

Ryner Lai

Researchers have sought to determine better ways to manage patients with SCD experiencing pain or a vaso-occlusive sickle cell crisis.

Cost and Allocation of Scarce CAR-T Therapy for Patients With Multiple Myeloma

By

Tori Rodriguez, MA, LPC, AHC

Researchers sought to determine the allocation and cost involved with CAR-T therapy for patients with multiple myeloma.

With Twitter (Now X) in Flux, Is #MedTwitter Under Threat?

By

Mark L. Fuerst

Oncology professionals share what #MedTwitter means to them and where they might go if Twitter (now X) becomes obsolete.

How Housing Insecurity Impacts Cancer Patients

By

Alan P. Lyss, MD

Housing insecurity can impede patients’ access to cancer screening, treatment, and survivorship care, increasing the risk of poor outcomes.

Physician Burnout

By

Emily Wagner, MS

Recent data reveal a staggering increase in reports of burnout among physicians.

How Food Insecurity Impacts Cancer Patients

By

Alan P. Lyss, MD

As many as 55% of patients with cancer may be affected by food insecurity.

AI in Medicine, Synthetic Datasets May Provide a New Tool for Hematologists

By

John Schieszer

Researchers sought to determine whether AI in medicine in the form of synthetic data would be applicable for hematologic malignancies.

Twinning: Collaboration Improves Pediatric Leukemia Care in LMICs

By

Tori Rodriguez, MA, LPC, AHC

Researchers sought to determine whether a “twinning” program would improve pediatric ALL outcomes in LMICs.

Insurance Reimbursement Challenges for Physicians

By

Takeesha Roland-Jenkins, PhD

As the costs of health care continue to increase, insurance reimbursements have become even more important for medical institutions to sustain their practices and expand optimal services.

How Transportation Insecurity Impacts Cancer Patients

By

Alan P. Lyss, MD

Cancer patients may be particularly susceptible to transportation-related disruptions in care.

Reticulocyte Hemoglobin Content: Early Marker of Iron-Deficiency Anemia

By

Charity Sorensen, PA-C

Rachel Ziganti, MPA, PA-C

Is reticulocyte hemoglobin content a better marker of iron deficiency anemia than ferritin and other traditional serum measurements?

Improving Care for Hematologic Neoplasms During Major Disruptions

By

John Schieszer

Researchers sought to determine ways to mitigate changes in visit rates among patients with hematologic neoplasms.

Untangling the Determinants of Pain in Sickle Cell Disease

By

Caleb Rans, PharmD

Researchers sought to determine the manifestations of sickle cell disease that are associated with pain and poor quality of life.

The Link Between Ambulatory Dysfunction and Mortality in Cancer Survivors

By

Tori Rodriguez, MA, LPC, AHC

Lower ambulatory function was observed across 9 cancer types, with the strongest associations observed in patients with respiratory and oral cancers.

What One Hospital’s Slow Recovery From a Cyberattack Means for Patients

By

Farah Yousry, Side Effects Public Media

In fall 2021, staffers at Johnson Memorial Health were hoping they could finally catch their breath. They were just coming out of a weeks-long surge of covid-19 hospitalizations and deaths, fueled by the delta variant.

Phase 3 Trials Explore Pirtobrutinib in CLL/SLL and MCL

By

Ariela Katz

Researchers are investigating pirtobrutinib in patients with CLL, SLL, and MCL.

ChatGPT and the Future of Health Care

By

Dipu Patel, DMSc, MPAS, PA-C

Vishal Patel

Experts describe how ChatGPT and other AI technologies will transform health care and research.

As Cancer Drug Shortages Increase, Patients’ Lives Are at Stake

By

Aaron Tallent

Oncology leaders testified before a House subcommittee about how drug shortages are hindering cancer care in the US and threatening the lives of patients.

ASCO 2023: Lymphoma Research Could Change Practice   

By

Tori Rodriguez, MA, LPC, AHC

Studies presented at the ASCO Annual Meeting 2023 highlighted new developments in lymphoma that could lead to changes in practice.

Patient-Derived iPSC Reprogramming Faithfully Models Human Acute Myeloid Leukemia Survival Rate

By

Tori Rodriguez, MA, LPC, AHC

Researchers sought to create patient-derived iPSC models that represent all major genetic classes of human acute myeloid leukemia, including the survival rate.

Lack of Access to Abortion Has Had a Negative Impact on Cancer Care

By

Tori Rodriguez, MA, LPC, AHC

Since the US Supreme Court overturned Roe v Wade last year, restrictions on access to abortion have had a negative impact on cancer care.

As COVID-19 Vaccine Recommendations Continue to Evolve, So Does Misinformation

By

Jayaram Daggumatti, PharmD, RPh, BCMAS

Erica Johnson, MD, discusses strategies to combat health misinformation in the wake of updates released by the CDC on recommendations for COVID-19 vaccination.

Hematologic Testing Considerations in Cases of Suspected Child Abuse, Non-Accidental Trauma

By

Caleb Rans, PharmD

New research raises questions about the applicability of expanded hematologic testing in cases of suspected child abuse or non-accidental trauma.

White Spaces Are Not Safe for Black Faces, Says Shondra J. Brown, FNP-BC

By

Jeanelle Jacobs

Shondra J Brown, FNP-BC, uses her platform to help Black professionals navigate predominantly White workplaces and encourages them not to conform.

State of Cancer Research: Impact of COVID-19, Brexit, War, and Other Global Events

By

Victoria Forster, PhD

In the last few years, cancer research has been hindered by the COVID-19 pandemic, Brexit, the war in Ukraine, and tensions between world superpowers.

ART and Pediatric Cancer: Risk May Vary by Method Used, Cancer Type

By

Carina Storrs, PhD

Research has suggested that ART may increase the risk of pediatric cancers, but studies have shown conflicting results, and questions remain.

Caring for the Caregivers of Patients With Hematologic Malignancies Undergoing HSCT

By

John Schieszer

Researchers sought to address the needs of caregivers of patients with hematologic malignancies undergoing HSCT.

Weighing the Efficacy and Toxicity of CAR T-Cell Therapy

By

Caleb Rans, PharmD

Researchers sought to determine the balance between the efficacy and toxicity when administering CAR T-cell therapy.

Disrupting the Status Quo: ACCESS Initiative Takes Aim at Inequities in HCT, Cellular Therapy

By

Jeffery Auletta, MD

Stella M. Davies, MBBS, PhD, MRCP

NMDP/Be The Match and the ASTCT seek to address inequities in HCT and cellular therapy.

Amazon’s Virtual Health Clinic Raises Patient Privacy Issues

By

John Schieszer, MA

How the retail giant will use the sensitive medical data it collects is among the concerns.

Ibrutinib No Longer Approved for MCL, MZL: How This Change Will Affect Patients

By

Mary Ellen Schneider

The withdrawn approvals of ibrutinib for relapsed/refractory MCL and MZL are likely to have a limited impact on patients, experts say.

Pregnancy Considerations for Patients With Chronic Myeloid Leukemia

By

Tori Rodriguez, MA, LPC, AHC

Researchers sought to determine the considerations needed for patients with chronic myeloid leukemia who conceive or wish to become pregnant while receiving TKI therapy.

Improving Risk Stratification in Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia in Children

By

John Schieszer

Researchers sought to better discriminate true MRD positivity for risk stratification in chronic lymphocytic leukemia and acute lymphoblastic leukemia in children.

Phase 2 Studies Investigate Combination Therapies, BCMA in Patients With Relapsed/Refractory Multiple Myeloma

By

Ariela Katz

Researchers are conducting phase 2 trials to assess various combination therapies, including BCMA, in patents with relapsed/refractory multiple myeloma.

Preventing and Treating COVID-19 in Cancer Patients: Challenges in the Omicron Era

By

Tori Rodriguez, MA, LPC, AHC

Methods to prevent and treat COVID-19 in cancer patients have had to evolve alongside the SARS-CoV-2 virus.

Tandem Meetings 2023: Research Shows Favorable Results for Lymphoma Subtypes

By

Ariela Katz

Research presented at the 2023 Tandem Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR demonstrated favorable results for various types of lymphoma.

Helping Clinicians Cope With Moral Distress Can Improve Patient Care

By

David Alfandre, MD, MSPH

A central objective of addressing moral distress is to permit clinicians to effectively perform their professional functions and thus better help patients.

Prioritizing Fertility Care in Sickle Cell Disease Treatment

By

Tori Rodriguez, MA, LPC, AHC

Researchers proposed that integrating standardized fertility care into SCD treatment is a requisite of high-quality, personalized care

Ponatinib Linked With Better Outcomes Than Imatinib in Philadelphia Chromosome-Positive ALL

By

Caleb Rans, PharmD

The phase 3 PhALLCON trial showed a trend toward improved EFS in patients with Ph+ newly diagnosed ALL when treated with ponatinib compared with imatinib.

Peer Support Essential for Young Adults Recovering From Cancer Treatment

By

Sara Grisales Jaramillo, LMSW CancerCare

A review of the importance family, friends, and a support system have on the cancer journey and survival outcomes for young adults with cancer.

EAHAD 2023: Treatments Show Promise for Hemophilia A and B

By

Ariela Katz

At EAHAD 2023, researchers reported positive results from trials of patients with hemophilia A and B, including those who are difficult to treat.

Cancer Patients May Fall Prey to Illegitimate Online Pharmacies

By

Tori Rodriguez, MA, LPC, AHC

High drug prices and ongoing shortages may prompt cancer patients to buy treatments online and fall prey to illegitimate pharmacies.

Red Cell Transfusion Supports Bone Marrow Health in Patients With Sickle Cell Disease

By

Tori Rodriguez, MA, LPC, AHC

Researchers sought to determine the utility of red blood cell transfusion in reducing bone marrow abnormalities in patients with SCD.

Improving End-of-Life Discussions With Cancer Patients

By

Tori Rodriguez, MA, LPC, AHC

Timely discussions about end-of-life preferences can ensure patients with advanced cancer receive care that aligns with their goals, experts say.

Moral Distress and the Health Care Professional

By

David Alfandre, MD, MSPH

Addressing moral distress means not just obtaining ethics consultation as needed but also dealing with the feeling of powerlessness that often accompanies it.

Black and Hispanic Patients Were More Likely to Delay Cancer Pharmacotherapy During the COVID-19 Pandemic

By

Jessica Nye, PhD

Researchers sought to determine whether there were delays in or discontinuation of treatment for cancer among different populations during the COVID-19 pandemic.

Sophisticated Cybercrime Group Targeting Health Care Providers

By

John Schieszer, MA

The FBI and other federal agencies have issued warnings about a ransomware and data extortion group called the Daixin Team.

Clinical Trials Testing Novel Combinations in Diffuse Large B-Cell Lymphoma

By

Ariela Katz

Researchers are conducting phase 2 and 3 trials to investigate novel treatment combinations for patients with DLBCL.

What the Buprenorphine X-Waiver Removal Means for Clinicians

By

Kristin Della Volpe

AANP and AAPA Presidents discuss how elimination of the X-Waiver and patient caps for buprenorphine prescription for opioid use disorder will affect clinical practice.

AML Research From ASH 2022: Novel Combinations and Evidence That “Less is More”

By

Tori Rodriguez, MA, LPC, AHC

AML research presented at ASH 2022 highlighted promising combination regimens and suggested that some patients may benefit from less intensive treatment.